Merck Lawsuit News and Information
Fosamax Lawsuit
The osteoporosis drug Fosamax, which is designed to strengthen bones and reduce the risk of fractures, has been linked to osteonecrosis of the jaw, which involves deterioration and death of the jaw bone. It has also been associated with osteonecrosis of the shoulder, osteonecrosis of the knee, osteonecrosis of the hip and a possible risk [...]
All Articles Tagged With: "Merck"
Jaw Decay Fosamax Lawsuits Heading to Trial in State and Federal Court
In the coming months, trials will start in federal court and state court for lawsuits filed by individuals who allege they suffered jaw damage from Fosamax, with federal trials in New York City scheduled to begin in April and June, and a New Jersey state court trial scheduled to begin in July.
FDA Reviewing Link Between Fosamax and Fractures
The FDA indicated this week that it is still investigating a potential link between unexplained femur fractures and osteoporosis drugs, like Fosamax, Actonel, Boniva and Reclast, but questions whether such a causal connection exists.
Trial Over Fosamax Jaw Damage Set to Begin April 19 in New York
A federal judge has denied attempts by Merck & Co. to have a Fosamax lawsuit thrown out, clearing the way for an April 19 trial to move forward involving allegations that the plaintiff developed permanent and debilitating jaw damage from Fosamax side effects.
Fosamax Jaw Necrosis Lawsuits in MDL Scheduled for Trial in April and June
U.S. District Judge John Keenan, who is presiding over the consolidated federal Fosamax lawsuits involving claims that the osteoporosis drug caused users to suffer debilitating jaw damage, has scheduled trial dates for “bellwether” cases to begin in April and June 2010.
Jaw Damage Lawsuit Against Fosamax Dismissed Weeks Before Trial
A federal judge has dismissed a lawsuit over Fosamax, saying that the plaintiff will be unable to establish at trial that the osteoporosis drug caused her to suffer debilitating jaw damage. The case had been scheduled for trial to begin on January 12, in what was to be the second of three bellwether trials [...]
Zetia, Vytorin Problems Continue With Latest Study
In the latest blow to popular cholesterol drugs Vytorin and Zetia, new research indicates that the medications may be less effective than older drugs in reducing the buildup of cholesterol in arteries, and were actually associated with more heart attacks and other heart-related incidents.
Second Fosamax Lawsuit Trial Set to Begin January 12
A firm trial date of January 12 has been scheduled for a Fosamax lawsuit against Merck & Co. over their popular osteoporosis drug, which alleges that the drug caused a woman to suffer severe and debilitating deterioration of the jaw, known as osteonecrosis of the jaw (ONJ).
Zometa Lawsuit Over Jaw Necrosis Heading to Jury
A Montana jury is expected to hear closing arguments today in the first Zometa lawsuit to go to trial, involving allegations that the bone strengthening cancer drug caused a woman to develop debilitating jaw problems.
Januvia Pancreatitis Problems Refuted by Merck
Following an FDA alert issued Friday about reports of acute pancreatitis associated with use of Januvia and Janumet, Merck & Co., the maker of both diabetes drugs, issued a statement refuting that Januvia side effects increase the risk of acute pancreatitis.
Contact a Lawyer
Submit information about your potential case to be reviewed by an attorney.
